Predictors of herpes simplex virus type 2 antibody positivity among persons with no history of genital herpes.
Sex Transm Dis., Nov;31(11):676-81 (2004)
Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya.
AIDS., Jan;20(1):41-8 (2006)
Incidence and prevalence of herpes simplex virus infections in adolescent women.
Sex Transm Dis., Jul;33(7):441-4 (2006)
Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial.
Mayo Clin. Proc., Oct;81(10):1321-7 (2006)
Effect of resiquimod 0.01% gel on lesion healing and viral shedding when applied to genital herpes lesions.
Antimicrob. Agents Chemother., Feb;52(2):477-82 (2008)
An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
Sex Transm Dis., Jul;35(7):668-73 (2008)
Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy.
J. Acquir. Immune Defic. Syndr., Jul;51(3):274-82 (2009)
Detection of multiple human papillomavirus types in condylomata acuminata from immunosuppressed patients.
J. Infect. Dis., Oct;170(4):759-65 (1994)
Human papillomavirus type 11 E1--E4 and L1 proteins colocalize in the mouse xenograft system at multiple time points.
Virology., Dec;214(1):259-63 (1995)
Cancer-associated human papillomavirus types are selectively increased in the cervix of women in the first trimester of pregnancy.
Am. J. Obstet. Gynecol., May;174(5):1487-93 (1996)
Functional characterization of the C---C chemokine-like molecules encoded by molluscum contagiosum virus types 1 and 2.
Proc. Natl. Acad. Sci. U.S.A., Sep;94(18):9875-80 (1997)
The intracellular expression pattern of the human papillomavirus type 11 E1--E4 protein correlates with its ability to self associate.
Virology., Feb;241(1):49-60 (1998)
A human papillomavirus related to human papillomavirus MM7/LVX82 produces distinct histological abnormalities in human foreskin implants grown as athymic mouse xenografts.
Virology., Sep;249(1):150-9 (1998)
Human papillomavirus vaccine development.
Australas. J. Dermatol., Nov;39 Suppl 1:S8-10 (1998)
Detection of multiple human papillomavirus types in Condylomata acuminata lesions from otherwise healthy and immunosuppressed patients.
J. Clin. Microbiol., Oct;37(10):3316-22 (1999)
Neutralization of human papillomavirus type 11 (HPV-11) by serum from women vaccinated with yeast-derived HPV-11 L1 virus-like particles: correlation with competitive radioimmunoassay titer.
J. Infect. Dis., Nov;184(9):1183-6 (2001)
Differences among mononuclear cell subpopulations in HIV seropositive or seronegative homosexual and heterosexual men as determined by four-color flow cytometry.
J. Acquir. Immune Defic. Syndr., 3(8):747-56 (1990)
Incidence of HIV infection in monocyte subpopulations characterized by CD4 and HLA-DR surface density.
AIDS., Feb;6(2):151-6 (1992)
Nucleotide sequence and characterization of human papillomavirus type 83, a novel genital papillomavirus.
Virology., Jul;260(1):165-72 (1999)
The human papillomavirus type 11 E1E4 protein is phosphorylated in genital epithelium.
Virology., Mar;268(2):430-9 (2000)